Product category:
Cell/tissue handling and counting
News Release from: Nexcelom Biosciences | Subject: Cellometer Auto T4
Edited by the Laboratorytalk Editorial
Team on 21 August 2006
Automatic cell counter is faster and
more accurate
Automatic cell counter provides scientists with an automated and standardized option over the manual hemacytometer for routine cell counting
Nexcelom Bioscience, an emerging provider of devices and instruments for cell-based assays used in cancer research and drug discovery, has launched its Cellometer Model Auto T4 cell counter The Auto T4 automates cell counting, a traditionally manual process that is time-consuming, tedious and susceptible to operator judgment, all of which can ultimately affect sample quality and produce inaccurate results
This article was originally published on Laboratorytalk on 21 Apr 2008 at 8.00am (UK)
Related stories
Automated cell counter has fluorescence detection
Nexcelom's Cellometer Vision is the latest addition to the line of Cellometer automated cell counters, which improves throughput by automating tedious manual counting procedures
Haematology analyser fills gap in range
With a throughput of 80 samples per hour, this will suit laboratories with workloads of up to 350 samples per day and fills the gap between 60 and 120 sample per hour machines
The Auto T4 has a small footprint of 3.5x4inches to optimise lab space and is very simple to operate.
Integral to the Auto T4 is the Cellometer patent-pending disposable counting chamber made of high quality plastic materials.
Samples are pipetted into the chamber and placed into the Auto T4, which connects to a computer via a USB cable.
Further reading
Innovative new products emphasise R and D
Completely new bench-top analyser combines the latest technological advances and a large test menu with a faster throughput
Getting the right haematology mix, automatically
Latest development to haematology analyser range incorporates a cutting edge fully integrated data management system that enables onboard validation of results
Neurite outgrowth assays for primary screening
High throughput, live cell, neurite outgrowth screens can be performed in 384 well plates at rates exceeding 30,000 compounds per day without compromising data quality
Imaging software automatically measures cell concentration and viability.
Cells within a heterogeneous sample with various sizes and morphology can also be measured, providing data not obtained by traditional methods.
The disposable chamber handles sample loading easily, requires minimal sample (20 microlitres), and eliminates washing steps.
Since the sample is completely contained within the disposable chamber, the Cellometer Auto T4 is free of cross-contamination and clogging.
Numerous cell counting and viability experiments have been conducted with the Auto T4 in comparison with using manual hemacytometers.
Same cell concentration results were measured over a wide range of cell conditions.
Application notes with further details are available from Nexcelom Bioscience.
"Scientists at the NCI and NIH who were customers of our Cellometer plastic disposable hemacytometer products have expressed a strong desire to further simplify cell counting." said Jean Qiu, president of Nexcelom Bioscience.
"We have designed the Auto T4 to satisfy that need.
"We provide an automated cell counting solution that is small in footprint and simple to use.
"It is affordable by each laboratory.
"Our customers told us that cells should be counted when experimental procedure requires it, but not when a centralized instrument is available.
"Communication with customers is the key.
"Without their important feedback, Nexcelom wouldn't be the successful company that it is today".
JW Hodge, senior scientist and director of the Recombinant Vaccine Group at the National Cancer Institute said: "The Auto T4 is a fantastic machine that saves our lab a lot of time.
"It is simple to use and small".
Headquartered in Lawrence, MA, close to Boston's biotech hub, Nexcelom Bioscience is an emerging designer, manufacturer and marketer of novel devices and instruments for cell-based assays used in cancer research and drug discovery.
Developed per researchers' requests, Nexcelom's solutions automate time-consuming procedures, enabling scientists to focus less on the process and more on the research results.
Nexcelom's products are currently being used in the labs of leading pharmaceutical companies, Biotech organisations, universities and research institutions.
• Nexcelom Biosciences: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
